Immunoglobulin heavy variable 3-32 (pseudogene) (IGHV3-32)

Immunoglobulin heavy variable 3-32 (IGHV3-32) refers to a segment of the immunoglobulin heavy chain variable region gene family, mapped to the IGHV locus on chromosome 14. The immunoglobulin heavy chain locus comprises numerous variable (V), diversity (D), joining (J), and constant (C) segments, each contributing to the generation of unique antibodies by B cells through processes such as V(D)J recombination, somatic hypermutation, and class switching. IGHV family segments encode the variable domain of the antibody heavy chain, which is a key determinant of antigen recognition and binding. Most references show "IGHV3-32" as a *pseudogene*, meaning it does not encode a functional protein product and therefore does not directly participate in immune signaling or serve as a therapeutic target. Functional IGHV segments (those that do encode antibody variable regions) are relevant in humoral immunity, but pseudogenes are essentially inactive. IGHV3-32 does not appear in major lists of functional IGHV alleles or as a therapeutic/receptor target in immunology or drug discovery literature, and no known drugs interact with it. The query refers to "IGHV3-32", but available resources, including Merck Millipore, classify it as a **pseudogene**, not a protein-coding gene/receptor. IGHV gene segments more broadly (such as IGHV3-23 or IGHV3-33) *can form the variable portion of immunoglobulin receptors*, but IGHV3-32 specifically is not a therapeutic target. The alternative names "3-29P" and "IGHV3-29" could reference related IGHV3 family segments, but are not canonical for IGHV3-32. If interest is in a *functional receptor or therapeutic target*, a different IGHV gene (one demonstrated as functional and protein-coding) must be selected. IGHV segments, as a family, contribute to antibody diversity and are critical to the immune response and recognition of pathogens. Active functional IGHV segments serve as templates for heavy chain variable regions of antibodies. In summary, IGHV3-32 is a genetic segment annotated primarily as a pseudogene, not a functional molecular target or therapeutic receptor, and its aliases/related names do not change its status. For immunotherapy, antibody engineering, or biomarker development, functional IGHV segments and their encoded receptors/antibodies are targeted instead.

Other names

IGHV3-323-29PIGHV329IGHV3-29